(Alliance News) - AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow this month to hopes for the product. Datopotamab deruxtecan, also ...
AstraZeneca updated the market on two ongoing drug trials on Monday, with a key trial in breast cancer failing to improve ...
In early UK corporate news, Rightmove received another takeover proposal from REA Group, though the Sydney listing bemoaned a lack of engagement. AstraZeneca backed the "clinical value" for its ...